Table 5.
Treatment stage | Vitamin B1 group | Placebo group | Result of test (Mann- Whitney) |
---|---|---|---|
Average of score + standard deviation | Average of score + standard deviation | ||
Before treatment | 34.19 ± 0.72 | 35.27 ± 0.98 | NS |
After one month treatment | 19.40 ± 0.63 | 33.51 ± 0.94 | 0.0001< P |
After two months treatment | 12.99 ± 0.63 | 30.51 ± 0.94 | 0.0001< P |
The average of reduction of general severity of the symptoms after treatment | 21.20 ± 0.63 | 4.76 ± 0.46 | 0.0001< P |
Intra – group difference | 0.0001< P | 0.001< P | |
(Wilcoxon test) |
The average physical symptoms severity of premenstrual syndrome has been reduced in Vitamin B1 group after treatment.